ies, Inc.
Althea Technologies is a fully integrated, contract development and manufacturing organization located in
San Diego, CA providing clinical and commercial product development services. Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Althea's formulation technology platform includes Crystalomics®, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. For more information, visit
www.altheatech.com.
About Profectus Biosciences.
Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of infectious diseases and related cancers, with the goal of reducing morbidity and mortality. Since its inception in 2003, the Company's strategic intent has been to acquire and develop the technologies needed to achieve this goal. The Company has licensed a group of vaccine?based technologies from Wyeth Vaccines (now Pfizer, Inc.) that greatly enhance the immunogenicity of prophylactic and therapeutic vaccines based on a "prime?boost" strategy. This strategy uses the delivery of a best?in?class pDNA vaccine to "prime" the immune system, followed by a first-in-class "boost" with an rVSV vector. Current disease and virus targets include hepatitis C virus (HCV), human papilloma virus (HPV), herpes simplex virus type 2 (HSV?2), human immunodeficiency virus (HIV), Ebola virus, Marburg Virus, the arenaviruses and malaria. The Profectus HIV DNA vaccine program has b
'/>"/>
SOURCE Althea Technologies, Inc. Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology news :1.
University of Colorado and Orphan Technologies sign agreement2.
Preclinical study shows potential of new technologies to detect response to cancer therapy earlier3.
LaserLock Technologies Files for Provisional Patent Enabling Mobile Phones with Anti-Counterfeiting Technology4.
Going negative: Stanford scientists explore new technologies that remove atmospheric CO25.
New modeling approach transforms imaging technologies6.
Life Technologies ayudará a identificar 20.000 restos humanos encontrados en fosas comunes en Libia7.
New supercomputer coming to EMSL this summer, supplied by Atipa Technologies8.
UT Dallas researchers awarded $4.3 million to create next-generation technologies9.
ASU partners with Life Technologies on US DHHS funded project to rapidly assess radiation dose10.
Lyncean Technologies Inc. sells Compact Light Source to Munich biomedical-imaging research center11.
NREL researchers use imaging technologies to solve puzzle of plant architecture